K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives-Reference-Cited by-同舟云学术

K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives

Published:2017-01 Issue: Volume:125 Page:299-314
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Asati Vivek^ORCID,Mahapatra Debarshi Kar,Bharti Sanjay Kumar

Funder

Indian Council of Medical Research

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference184 articles.

1. The path to routine use of genomic biomarkers in the cancer clinic;Boutros;Genome Res.,2015

2. Cancer biomarkers - current perspectives;Bhatt;Indian J. Med. Res.,2010

3. Genetic tests and genomic biomarkers: regulation, qualification and validation;Novelli;Clin. Cases Min. Bone Metab.,2008

4. K-Ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers–a review;Minamoto;Cancer Detect Prev.,2000

5. Control of ras cycling by Ca2+;Walker;FEBS Lett.,2003

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene selection and cancer classification using interaction-based feature clustering and improved-binary Bat algorithm;Computers in Biology and Medicine;2024-10

2. Development of erythrina-based PARP-1/FTase dual-target inhibitors against lung cancer epithelial-mesenchymal transition (EMT) in vivo and in vitro;Bioorganic Chemistry;2024-07

3. Recent Advances in Signaling Pathways and Kinase Inhibitors for Leukemia Chemotherapy;Current Medicinal Chemistry;2024-02-16

4. An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review;Molecular Diversity;2024-01-30

5. Exercise as a Promising Agent against Cancer: Evaluating Its Anti-Cancer Molecular Mechanisms;Cancers;2023-10-25